Overview

In this 2-year invitation-only program, companies receive up to $100,000 CAD in funding, rent-free placement in one of CBV’s fully equipped lab spaces, and up to 300 hours per year of consulting services with CBV EIRs and Managing Directors. In addition, companies have direct access to CBV leadership, with quarterly check-in meetings to review progress, identify risks, and prioritize.

What's Included?

Up to $100K in funding.

Access to rent-free, move in ready, fully outfitted wet-lab and office space with concierge lab service for 2 years.

Up to 300hrs/year of consulting services with quarterly meetings with CBV leadership.

Access to monthly seminars/panels and group office hours.

Access to CBV templates, resources and networking events.

Pitch practice sessions, test-the-waters sessions with investors, and CBV representation at conferences.

Introductions to wet-lab partners and pre-vetted CDMOs and CROs.

Subsidized rates to access CBV core facilities and CBV-partnered facilities.

Access & complimentary use of CBV equipment.

Group discounts with lab vendors and service providers.

Eligibility Criteria

Canadian seed staged therapeutics or in-vitro diagnostic companies based in Southern Ontario.

At least 2 FTE.

TRL 4+.

Raised a minimum of $500K (dilutive & non-dilutive) with at least 2 investors.

Application Process

Program Inquiry

For questions about the program, eligibility, or the application process contact us below.

Important

Access to SUMMIT is by invitation only and open only to CBV portfolio companies (ie: those that have participated in ASCENT and/or RIDGE). Companies must undergo a due diligence process to be considered for the SUMMIT program.

Testimonials

While we have benefited from past accelerators, CBV stands out by becoming a true, enduring partner. Over 18 months, their deep, hands-on involvement, whether through lab space, capital, and expertise, has been pivotal in advancing our pipeline and securing global partnerships. CBV’s commitment has truly driven lasting, meaningful success for NuvoBio and our DarwinAI platform.

NuvoBio (Kyle Biggar, CSO)

Since September 2024, CBV has been an instrumental partner, providing essential and comprehensive support across several critical operational areas to accelerate our growth... The breadth and depth of CBV's partnership have been foundational to our significant strides this past year.

Rhythm Biotherapeutics (Darryl Davis, CEO).

CBV has been an invaluable partner during a pivotal chapter for Yellowbird Diagnostics. With their hands-on approach and deep industry expertise, the CBV team helped us scale our operations and reach critical milestones, including first-in-human imaging and Phase I clinical trial approval.

Yellowbird Diagnostics (Nicholas D. Calvert, CEO)

Capital BioVentures is an Ottawa Canada founded wet-lab accelerator program that removes hurdles for our Canadian innovators, while fostering a collaborative and cohesive ecosystem.

Company

About Us Portfolio Programs Labs & Services Our Experts News & Events

Subscribe to our mailing list

SUMMIT